Your browser doesn't support javascript.
loading
Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of ß- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy.
Horie, Ichiro; Haraguchi, Ai; Sako, Ayaka; Akeshima, Junya; Niri, Tetsuro; Shigeno, Riyoko; Ito, Ayako; Nozaki, Aya; Natsuda, Shoko; Akazawa, Satoru; Mori, Yoshitaka; Ando, Takao; Kawakami, Atsushi; Abiru, Norio.
Afiliación
  • Horie I; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan. Electronic address: holy197741@me.com.
  • Haraguchi A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Sako A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Akeshima J; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Niri T; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Shigeno R; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Ito A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Nozaki A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Natsuda S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Akazawa S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Mori Y; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Ando T; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Kawakami A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
  • Abiru N; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.
Diabetes Res Clin Pract ; 144: 161-170, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30194951
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagón / Células Secretoras de Insulina / Péptido 1 Similar al Glucagón / Liraglutida / Hipoglucemiantes / Insulina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagón / Células Secretoras de Insulina / Péptido 1 Similar al Glucagón / Liraglutida / Hipoglucemiantes / Insulina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article